Camlin Fine Sciences Limited (BOM:532834)

Market Cap	26.81B +1.7%
Revenue (ttm)	17.78B +7.5%
Net Income	-612.99M
EPS	-3.28
Shares Out	192.09M
PE Ratio	n/a
Forward PE	29.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,627
Average Volume	43,247
Open	139.70
Previous Close	139.65
Day's Range	132.65 - 141.40
52-Week Range	128.10 - 334.70
Beta	0.22
RSI	40.79
Earnings Date	May 18, 2026

About Camlin Fine Sciences

Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hy...

• Industry: Chemicals and Allied Products
• Founded: 1931
• Employees: 661
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532834

Financial Performance

In fiscal year 2025, Camlin Fine Sciences's revenue was 16.67 billion, an increase of 14.62% compared to the previous year's 14.54 billion. Losses were -1.39 billion, 49.9% more than in 2024.